少量非経口薬の世界市場レポート 2025年

少量非経口薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.6％で2,685億3,000万米ドルに成長します。予測期間の成長は、生物製剤市場の拡大、ヘルスケアインフラの開拓、入院率の増加、規制当局の承認、在宅医療へのシフト、ヘルスケアへの投資増加、世界の健康危機などに起因すると考えられます。予測期間における主な動向としては、生体適合製剤の成長、患者中心のアプローチ、在宅医療の増加、製造自動化の進展、治療領域の拡大、スマートポンプ技術などが挙げられます。

今後、手術件数の増加が少量非経口薬市場の拡大を牽引すると予想されます。手術は、病気や怪我などの症状の治療や診断、身体機能や外観の向上、損傷部位の修復のために手術技術を用いる医療分野です。外科手術の増加は、医療技術の進歩や高齢化によってもたらされ、外科的介入に対する需要の高まりにつながっています。少量の非経口溶液は手術において極めて重要であり、薬物、電解質、栄養素を血流に直接正確に投与することを可能にします。例えば、2023年8月、米国を拠点とする形成外科と美容医療の団体であるThe Aesthetic Societyは、米国人が美容整形に費やした金額は118億米ドルを超え、前年比2％増であったと報告しました。その結果、手術件数の増加が少量非経口剤市場の成長に拍車をかけています。

少量非経口製剤市場の主要企業は、市場収益を高めるため、内蔵型凍結乾燥機などの革新的ソリューションの開発に注力しています。ビルトイン凍結乾燥機は、製品を凍結乾燥させて凍結乾燥粉末を製造する製造ライン内の統合システムであり、多くの場合、特定の非経口薬に使用されます。例えば、2022年1月、中国の製薬会社であるWuXi STA社は、新しい非経口製剤製造ラインを立ち上げました。無錫にある無菌製造工場と併設されたこの新しい施設は、米国FDA、EMA、中国NMPAが定めたcGMP基準に準拠して設計されています。このラインには、最新世代の隔離システムと充填機が組み込まれており、充填工程全体が完全に隔離された環境でロボットにより自動化されています。このセットアップにより、人の介入を最小限に抑え、汚染を防止し、高品質の製品生産を保証しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界少量非経口薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の少量非経口薬市場：成長率分析
• 世界の少量非経口薬市場の実績：規模と成長, 2019-2024
• 世界の少量非経口薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界少量非経口薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の少量非経口薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アンプル
• バイアル
• プレフィルドシリンジ
• 世界の少量非経口薬市場投与量の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単回投与
• 複数回投与
• 世界の少量非経口薬市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理
• がんケア
• 栄養失調
• 胃腸障害または下痢
• 糖尿病
• その他の適応症
• 世界の少量非経口薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所麻酔薬
• ワクチン
• その他の用途
• 世界の少量非経口薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 外来手術センター
• その他のエンドユーザー
• 世界の少量非経口薬市場アンプルの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ガラスアンプル
• プラスチックアンプル
• 世界の少量非経口薬市場バイアルの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ガラスバイアル
• プラスチックバイアル
• 単回投与バイアル
• マルチドーズバイアル
• 世界の少量非経口薬市場プレフィルドシリンジの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ガラスプレフィルドシリンジ
• プラスチック製プレフィルドシリンジ

第7章 地域別・国別分析

• 世界の少量非経口薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の少量非経口薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 少量非経口薬市場：競合情勢
• 少量非経口薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• GlaxoSmithKline plc
• Eli Lilly and Company
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Fresenius Kabi AG
• Sun Pharmaceutical Industries Ltd.
• Boehringer Ingelheim GmbH
• Viatris Inc
• Intas Pharmaceuticals Ltd.
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Hikma Pharmaceuticals PLC
• Lupin Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 少量非経口薬市場2029：新たな機会を提供する国
• 少量非経口薬市場2029：新たな機会を提供するセグメント
• 少量非経口薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Small volume parenteral (SVP) relates to a classification of sterile pharmaceuticals designed for parenteral delivery (circumventing the gastrointestinal tract) and usually dispensed in volumes of 100 milliliters (mL) or smaller. These items serve diverse medical functions, such as administering medications, vaccines, or biological therapies directly into the body via intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes.

The primary categories of small volume parenteral include ampules, vials, and prefilled syringes. Ampules are compact, sealed containers utilized for storing and protecting liquid medications, typically opened by breaking off the neck. Available in single or multiple doses, they are employed to address diverse conditions such as pain management, cancer treatment, malnutrition, gastrointestinal issues, diabetes, among others. Widely used in local anesthetics, vaccines, and similar applications, they cater to various end users including hospitals, clinics, ambulatory surgical centers, and others.

The small volume parenteral market research report is one of a series of new reports from The Business Research Company that provides small volume parenteral market statistics, including small volume parenteral industry global market size, regional shares, competitors with a small volume parenteral market share, detailed small volume parenteral market segments, market trends and opportunities, and any further data you may need to thrive in the small volume parenteral industry. This small volume parenteral market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small volume parenteral market size has grown strongly in recent years. It will grow from $177.26 billion in 2024 to $193.16 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, regulatory approvals and government initiatives, pharmaceutical outsourcing trends, and globalization and expansion of pharmaceutical markets.

The small volume parenteral market size is expected to see strong growth in the next few years. It will grow to $268.53 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the expansion of the biologics market, healthcare infrastructure development, increased hospitalization rates, regulatory approvals, a shift toward home healthcare, rising investment in healthcare, and global health crises. Major trends in the forecast period include growth in biocompatible formulations, patient-centric approaches, rise in home healthcare, advancements in manufacturing automation, expansion in therapeutic areas, and smart pump technologies.

The growing number of surgeries is expected to drive the expansion of the small-volume parenteral market in the future. Surgery is a medical field that involves using operative techniques to treat or diagnose conditions such as diseases or injuries, enhance bodily function or appearance, or repair damaged areas. The rise in surgical procedures is driven by advancements in medical technology and an aging population, leading to greater demand for surgical interventions. Small-volume parenteral solutions are crucial in surgeries, allowing for the precise administration of medications, electrolytes, and nutrients directly into the bloodstream. For example, in August 2023, The Aesthetic Society, a U.S.-based organization for plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures, a 2% increase from the previous year. As a result, the growing number of surgeries is fueling the growth of the small-volume parenteral market.

Major companies in the small-volume parenteral market are concentrating on developing innovative solutions, such as built-in lyophilizers, to enhance their market revenue. A built-in lyophilizer is an integrated system within the manufacturing line that freezes and dries products to produce lyophilized powders, often used for specific parenteral drugs. For example, in January 2022, WuXi STA, a pharmaceutical company based in China, launched a new parenteral formulation manufacturing line. This new facility, alongside its sterile manufacturing plant in Wuxi, is designed in compliance with cGMP standards set by the U.S. FDA, EMA, and China NMPA. The line incorporates the latest generation of isolation systems and filling machines, with the entire filling process being automated by robotics in a fully isolated environment. This setup minimizes human intervention and prevents contamination, ensuring high-quality product output.

In February 2024, Eris Lifesciences Ltd., a pharmaceutical firm headquartered in India, acquired a majority stake of 51% in Swiss Parenteral for $76.52 million. This strategic move by Eris enhances its footprint in the sterile injectables sector and aligns with its strategy of targeting emerging markets. Swiss Parenteral, also based in India, specializes in the production of small-volume liquid parenteral formulations within the pharmaceutical industry.

Major companies operating in the small volume parenteral market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Viatris Inc, Intas Pharmaceuticals Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Alembic Pharmaceuticals Ltd., Wockhardt Ltd.

North America was the largest region in the small volume parenteral market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the small volume parenteral market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The small volume parenteral market consists of sales of epinephrine, insulin, heparin, morphine, and vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Volume Parenteral Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small volume parenteral market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small volume parenteral ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The small volume parenteral market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Ampules; Vials; Prefilled Syringes
• 2) By Dose Type: Single Dose; Multiple Dose
• 3) By Indication Type: Pain Management; Cancer Care; Malnourishment; Gastrointestinal Disorder Or Diarrhea; Diabetes; Other Indications
• 4) By Application: Local Anesthetics; Vaccines; Other Applications
• 5) By End User: Hospitals; Clinics; Ambulatory Surgical Center; Other End Users
• Subsegments:
• 1) By Ampules: Glass Ampules; Plastic Ampules
• 2) By Vials: Glass Vials; Plastic Vials; Single-dose Vials; Multi-dose Vials
• 3) By Prefilled Syringes: Glass Prefilled Syringes; Plastic Prefilled Syringes
• Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Small Volume Parenteral Market Characteristics

3. Small Volume Parenteral Market Trends And Strategies

4. Small Volume Parenteral Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Small Volume Parenteral Growth Analysis And Strategic Analysis Framework

• 5.1. Global Small Volume Parenteral PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Small Volume Parenteral Market Growth Rate Analysis
• 5.4. Global Small Volume Parenteral Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Small Volume Parenteral Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Small Volume Parenteral Total Addressable Market (TAM)

6. Small Volume Parenteral Market Segmentation

• 6.1. Global Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ampules
• Vials
• Prefilled Syringes
• 6.2. Global Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Dose
• Multiple Dose
• 6.3. Global Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Cancer Care
• Malnourishment
• Gastrointestinal Disorder Or Diarrhea
• Diabetes
• Other Indications
• 6.4. Global Small Volume Parenteral Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Local Anesthetics
• Vaccines
• Other Applications
• 6.5. Global Small Volume Parenteral Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgical Center
• Other End Users
• 6.6. Global Small Volume Parenteral Market, Sub-Segmentation Of Ampules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glass Ampules
• Plastic Ampules
• 6.7. Global Small Volume Parenteral Market, Sub-Segmentation Of Vials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glass Vials
• Plastic Vials
• Single-dose Vials
• Multi-dose Vials
• 6.8. Global Small Volume Parenteral Market, Sub-Segmentation Of Prefilled Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glass Prefilled Syringes
• Plastic Prefilled Syringes

7. Small Volume Parenteral Market Regional And Country Analysis

• 7.1. Global Small Volume Parenteral Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Small Volume Parenteral Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Small Volume Parenteral Market

• 8.1. Asia-Pacific Small Volume Parenteral Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Small Volume Parenteral Market

• 9.1. China Small Volume Parenteral Market Overview
• 9.2. China Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Small Volume Parenteral Market

• 10.1. India Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Small Volume Parenteral Market

• 11.1. Japan Small Volume Parenteral Market Overview
• 11.2. Japan Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Small Volume Parenteral Market

• 12.1. Australia Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Small Volume Parenteral Market

• 13.1. Indonesia Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Small Volume Parenteral Market

• 14.1. South Korea Small Volume Parenteral Market Overview
• 14.2. South Korea Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Small Volume Parenteral Market

• 15.1. Western Europe Small Volume Parenteral Market Overview
• 15.2. Western Europe Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Small Volume Parenteral Market

• 16.1. UK Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Small Volume Parenteral Market

• 17.1. Germany Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Small Volume Parenteral Market

• 18.1. France Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Small Volume Parenteral Market

• 19.1. Italy Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Small Volume Parenteral Market

• 20.1. Spain Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Small Volume Parenteral Market

• 21.1. Eastern Europe Small Volume Parenteral Market Overview
• 21.2. Eastern Europe Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Small Volume Parenteral Market

• 22.1. Russia Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Small Volume Parenteral Market

• 23.1. North America Small Volume Parenteral Market Overview
• 23.2. North America Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Small Volume Parenteral Market

• 24.1. USA Small Volume Parenteral Market Overview
• 24.2. USA Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Small Volume Parenteral Market

• 25.1. Canada Small Volume Parenteral Market Overview
• 25.2. Canada Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Small Volume Parenteral Market

• 26.1. South America Small Volume Parenteral Market Overview
• 26.2. South America Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Small Volume Parenteral Market

• 27.1. Brazil Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Small Volume Parenteral Market

• 28.1. Middle East Small Volume Parenteral Market Overview
• 28.2. Middle East Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Small Volume Parenteral Market

• 29.1. Africa Small Volume Parenteral Market Overview
• 29.2. Africa Small Volume Parenteral Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Small Volume Parenteral Market, Segmentation By Dose Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Small Volume Parenteral Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Small Volume Parenteral Market Competitive Landscape And Company Profiles

• 30.1. Small Volume Parenteral Market Competitive Landscape
• 30.2. Small Volume Parenteral Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Small Volume Parenteral Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. GlaxoSmithKline plc
• 31.3. Eli Lilly and Company
• 31.4. Baxter International Inc.
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Fresenius Kabi AG
• 31.7. Sun Pharmaceutical Industries Ltd.
• 31.8. Boehringer Ingelheim GmbH
• 31.9. Viatris Inc
• 31.10. Intas Pharmaceuticals Ltd.
• 31.11. Aurobindo Pharma Limited
• 31.12. Dr. Reddy's Laboratories Ltd.
• 31.13. Cipla Limited
• 31.14. Hikma Pharmaceuticals PLC
• 31.15. Lupin Limited

32. Global Small Volume Parenteral Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Small Volume Parenteral Market

34. Recent Developments In The Small Volume Parenteral Market

35. Small Volume Parenteral Market High Potential Countries, Segments and Strategies

• 35.1 Small Volume Parenteral Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Small Volume Parenteral Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Small Volume Parenteral Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer